Can Stem Cell Therapy Become an Integral Part of Our Health Care?

Stem cells are cells found in most, if not all,professional bodies within the EU which has
multi-cellular organisms. They are the buildingresulted in a somewhat fragmented approach
blocks of the body which have the ability towith decisions having to be made on a national
renew themselves through mitotic cell division andbasis. This is time consuming, inefficient and costly.
differentiate into a diverse range of specialised cellCurrently there are proposals being debated in the
types such as muscle or nerve cells. Scientists areEuropean Parliament which, hopefully, will go some
learning how to 'tweak' stem cells so that theyway to resolving this. It has taken many years to
can be used to treat degenerative diseases etc.get to where we are today and it is likely to take
When IVF was first announced it was frownedat least another decade before we reach any
upon but now it is accepted as being a normal andlevel of true harmonisation.
fairly routine procedure. Given enough time toEurope isn't on its own in having a fragmented
raise awareness of the benefits of stem cellapproach to stem cell therapies. America's
therapy it is anticipated that, like IVF, it willregulations vary considerably from State to State
become accepted practice. In fact, cell therapy isand under the Bush administration federal funding
currently being used for the treatment of patientsfor stem cell medical research has been
with leukemia so already there is a certain level ofextremely limited. The new US President, Barack
public acceptance for this type of treatment.Obama, however, has stated that he will lift the
Patient groups such as the Parkinson's Society arerestrictions imposed by President Bush. "I believe
encouraging the use of stem cell therapy by thethat the restrictions that President Bush has
very nature of the disease itself. It is thoseplaced on funding of human embryonic stem cell
people suffering from slowly degenerativeresearch have handcuffed our scientists and
diseases who are most likely to push for clinicalhindered our ability to compete with other
trials in man. It may be too late to help them butnations," he said. As president, Obama says he will
they are keen to help treat subsequent sufferersguarantee that all research on stem cells is
with the aim of eradicating the disease altogether.conducted "ethically and with rigorous
In addition, we have an ageing population which isoversight."[2] Europe is waiting to see what
yet another reason why there is a greaterhappens with Obama at the helm of the US
demand for research into cell and organbecause it is likely that whatever happens in
replacement therapies.America will also have an impact on regulations
The commercial aspect of stem cell therapywithin the EEC.
should not be overlooked. There are existingIn the meantime, it is important that we do not
treatments which, in the future, could be replacedlose sight of the fact that the research and
with stem cell therapy. For example, the currentdevelopment of stem cell therapies has huge
treatment for patients with age-related macularpotential for human health. It took many years
degeneration (AMD) is a 4 to 6 weekly injection infor IVF to become a normal part of our
the diseased eye at a cost of £1,200 perhealthcare system. Given enough time to raise
injection. These injections could be replaced withpublic awareness and to harmonise legal and
the use of embryonic stem cells. A procedureregulatory systems, stem cell therapy will also
which would take 40 minutes and last 2 to 3become accepted treatment. In the transition
years at an approximate cost of £5,000.[1]phase regulatory compliance consultants like GRS
This one example demonstrates a considerablecontinue to monitor and offer advice to
saving and most importantly, improvement to theorganisations at the leading edge of healthcare
patient's quality of life.technology.
Stem cell activities are regulated by different